A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects

References

• Cajot S, Butsele KV, Paillard A, et al. (2012). Smart nanocarriers for pH-triggered targeting and release of hydrophobic drugs. Acta Biomater 8:4215–23
   PubMed Web of Science ®Google Scholar
• Cen P, Ni XL, Yang JX, et al. (2012). Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochimica et Biophysica Acta 1826:350–6
   PubMed Web of Science ®Google Scholar
• Chi YS, Cheon BS, Kim HP. (2001). Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 61:1195–203
   PubMed Web of Science ®Google Scholar
• Dong P, Zhang Y, Gu J, et al. (2011). Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. J Ethnopharmaco 137:1373–80
   PubMed Web of Science ®Google Scholar
• Guo Q, Zhao L, You Q, et al. (2007). Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antivir Res 74:16–24
   PubMed Web of Science ®Google Scholar
• He ZY, Zheng X, Wu XH, et al. (2010). Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int J Pharm 397:147–54
   PubMed Web of Science ®Google Scholar
• Himeji M, Ohtsuki T, Fukazawa H, et al. (2007). Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell. Cancer Lett 245:269–74
   PubMed Web of Science ®Google Scholar
• Huang KF, Zhang GD, Huang YQ, et al. (2012). Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int Immunopharmacol 12:334–41
   PubMed Web of Science ®Google Scholar
• Huang W, Wang W, Wang P, et al. (2010). Glycyrrhetinic acid-modified poly (ethyleneglycol) – b – poly (γ – benzyl L-glutamate) micelles for liver targeting therapy. Acta Biomater 6:3927–35
   PubMed Web of Science ®Google Scholar
• Huang W, Wang W, Wang P, et al. (2011). Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier. J Mater Sci Mater Med 22:853–63
   PubMed Web of Science ®Google Scholar
• Il’icheva TN, Proniaeva TR, Smetannikov AA, et al. (1998). Content of progesterone, glucocorticoid and glycyrrhizic acid receptors in normal and tumoral human breast tissue. Vopr Onkol 44:390–4
   PubMedGoogle Scholar
• Jain RK, Stylianopoulos T. (2010). Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653–64
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee TH, Jung CH, et al. (2012). Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells. Cell Signal 24:2216–25
   PubMed Web of Science ®Google Scholar
• Li J, Ke X. (2011). Preparation of docetaxel liposomes surface-modified with glycyrrhetinic acid and its in vitro anti-tumor effect. Pharm Clin Res 19:207–10
   Google Scholar
• Li J, Xu H, Ke X, et al. (2012). The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid. J Drug Target 20:467–73
   PubMed Web of Science ®Google Scholar
• Lim JS, Yoo M, Kwon HJ, et al. (2010). Wogonin induces differentiation and neurite outgrowth of neural precursor cells. Biochem Bioph Res Co 402:42–7
   PubMed Web of Science ®Google Scholar
• Li-Weber M. (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35:57–68
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao YZ, Wu Y, et al. (2011). Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol 68:343–8
   PubMed Web of Science ®Google Scholar
• Lu N, Gao Y, Ling Y, et al. (2008). Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci 82:956–63
   PubMed Web of Science ®Google Scholar
• Mao SJ, Bi YQ, Jin H, et al. (2007). Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazie 62:614–9
   PubMed Web of Science ®Google Scholar
• Negishi M, Irie A, Nagata N, et al. (1991). Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta 1066:77–82
   PubMed Web of Science ®Google Scholar
• Park HG, Yoon SY, Choi JY, et al. (2007). Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur J Pharmacol 574:112–9
   PubMed Web of Science ®Google Scholar
• Peng J, Qi Q, You Q, et al. (2009). Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs. J Ethnopharmacol 124:257–62
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. (2012). Challenges in development of targeted liposomal therapeutics. AAPS J 14:303–11
   PubMed Web of Science ®Google Scholar
• Shieh DE, Liu LT, Lin CC. (2000). Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 20:2861–5
   PubMed Web of Science ®Google Scholar
• Tian Q, Wang W, He XT, et al. (2009). Glycyrrhetinic acid-modified nanoparticles for drug delivery: preparation and characterization. Chin Sci Bull 54:3121–6
   Web of Science ®Google Scholar
• Tian Q, Wang X, Wang W, et al. (2010a). Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting. Int J Pharm 400:153–7
   PubMed Web of Science ®Google Scholar
• Tian Q, Zhang CN, Wang XH, et al. (2010b). Glycyrrhetinic acidmodified chitosan/poly(ethylene glycol) nanoparticles for livertargeted delivery. Biomaterials 31:4748–56
   PubMed Web of Science ®Google Scholar
• Tian Q, Wang XH, Wang W, et al. (2012). Self-assembly and liver targeting of sulfate chitosan nanoparticles functionalized with glycyrrhetinic acid. Nanomed Nanotechnol 8:870–9
   PubMed Web of Science ®Google Scholar
• Yang L, You Q, Yang Y, Guo Q. (2009). Research advances in wogonin’s anti-tumor effects. J Chin Pharm Univ 40:576–9
   Google Scholar
• Yang XY, Li YX, Li M, et al. (2012). Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett 334:338–45
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen Z, Zhao Q, et al. (2011a). Developmental toxicity and genotoxicity studies of wogonin. Regul Toxicol Pharm 60:212–7
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Sun CZ, Lu CT, et al. (2011b). Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Lett 311:187–94
   PubMed Web of Science ®Google Scholar